1 / 2
google
Article details
- Package size
- 8
- Selling units
- 8
- Measure
- Kapsel(n)
- Galenic form
- Kapseln
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
50.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 17.75
Specialties list
Yes
Generic
No
SL addition date:
15/03/1978
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 34279
- Drug name
- Rimactan, Kapseln
- Galenic form
- KAHA
- ATC Code
- J04AB02
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 19/07/1968
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.02.1.
- Domain
- Human medicine
Package details
- Description (FR)
- RIMACTAN caps 300 mg 8 pce
- Description (DE)
- RIMACTAN Kaps 300 mg 8 Stk
- Market launch
- 05/05/1970
- Narcotic (BTM)
- No